The UHM Vacation IPO is scheduled to open for subscription on June 4, 2026, and…
Q-Line Biotech IPO Date, Review, Price, Allotment Details
Q-Line Biotech IPO open date is 2026 and the IPO will close on 2026. Q-Line Biotech IPO is a Book build Issue. The company plans to raise around ₹[.] crores through the IPO, which consists of a fresh issue of ₹[.] crores and an offer for sale of up to [.] equity shares with a face value of ₹10 each.
Q-Line Biotech IPO price band is ₹[.] to ₹[.] per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Q-Line Biotech IPO is proposed to list on NSE in 2026, while the allotment date for the IPO is also scheduled in 2026.
The company reported revenue of ₹322.58 crores in 2025 compared to ₹206.45 crores in 2024. It posted a profit of ₹28.13 crores in 2025 against a profit of ₹34.44 crores in 2024. Based on the financial performance, long-term investors may consider applying for the IPO.
Q-Line Biotech IPO Details
| IPO Open Date | 2026 |
| IPO Close Date | 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹[.] to ₹[.] Per Share |
| Issue Size | Approx ₹[.] Crores, 70,53,200 Equity Shares |
| Fresh Issue | Approx ₹[.] Crores, 70,53,200 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
Q-Line Biotech IPO Dates
| IPO Open Date: | 2026 |
| IPO Close Date: | 2026 |
| Basis of Allotment: | 2026 |
| Refunds: | 2026 |
| Credit to Demat Account: | 2026 |
| IPO Listing Date: | 2026 |
| IPO Bidding Cut-off Time: | 2026 – 5 PM |
Q-Line Biotech is a leading Indian In-Vitro Diagnostics (IVD) company established in 2008 and headquartered in Lucknow, Uttar Pradesh. The company specializes in the development, manufacturing, and distribution of diagnostic instruments, rapid testing kits, pathology equipment, biochemistry reagents, and laboratory solutions. Operating under the “Make in India” initiative, Q-Line Biotech focuses on indigenous manufacturing of products such as gold nanoparticles, magnetic beads, hematology reagents, urine strips, ELISA kits, and various biochemistry parameters for the healthcare and diagnostics sector.
The company serves a broad customer base that includes hospitals, medical colleges, diagnostic laboratories, and corporate healthcare chains across India. Q-Line Biotech has built a strong international presence by exporting its products to more than 50 countries worldwide. It follows strict quality and compliance standards and holds certifications including ISO 9001:2015 and ISO 13485:2016. With a focus on innovation, quality diagnostics, and expanding healthcare access, the company continues to strengthen its position in the medical diagnostics and pathology equipment industry.
Related Posts
